174 related articles for article (PubMed ID: 38928130)
1. Targeting Protein Kinases to Protect Beta-Cell Function and Survival in Diabetes.
Dalle S
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928130
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibitors of β-cell dysfunction and death as therapeutics for diabetes.
Dalle S; Abderrahmani A; Renard E
Front Endocrinol (Lausanne); 2023; 14():1076343. PubMed ID: 37008937
[TBL] [Abstract][Full Text] [Related]
3. Diabetic Kinome Inhibitors-A New Opportunity for β-Cells Restoration.
Pucelik B; Barzowska A; Dąbrowski JM; Czarna A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445786
[TBL] [Abstract][Full Text] [Related]
4. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors: impact on glucose metabolism.
Boj-Carceller D
Endocrine; 2013 Feb; 43(1):22-32. PubMed ID: 22886351
[TBL] [Abstract][Full Text] [Related]
6. Protein Kinase CK2-A Putative Target for the Therapy of Diabetes Mellitus?
Ampofo E; Nalbach L; Menger MD; Montenarh M; Götz C
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500224
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes.
Moon JH; Choe HJ; Lim S
J Diabetes Investig; 2024 Jun; 15(6):669-683. PubMed ID: 38676410
[TBL] [Abstract][Full Text] [Related]
8. Beta cell mass in diabetes: a realistic therapeutic target?
Meier JJ
Diabetologia; 2008 May; 51(5):703-13. PubMed ID: 18317728
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes.
Prada PO; Saad MJ
Expert Opin Investig Drugs; 2013 Jun; 22(6):751-63. PubMed ID: 23705634
[TBL] [Abstract][Full Text] [Related]
10. GLP-1 agonists in type 1 diabetes.
Pettus J; Hirsch I; Edelman S
Clin Immunol; 2013 Dec; 149(3):317-23. PubMed ID: 23643354
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase inhibitors under investigation for the treatment of type II diabetes.
Malek R; Davis SN
Expert Opin Investig Drugs; 2016; 25(3):287-96. PubMed ID: 26765364
[TBL] [Abstract][Full Text] [Related]
13. An arduous journey from human pluripotent stem cells to functional pancreatic β cells.
Loo LSW; Lau HH; Jasmen JB; Lim CS; Teo AKK
Diabetes Obes Metab; 2018 Jan; 20(1):3-13. PubMed ID: 28474496
[TBL] [Abstract][Full Text] [Related]
14. Targeting the pancreatic β-cell to treat diabetes.
Vetere A; Choudhary A; Burns SM; Wagner BK
Nat Rev Drug Discov; 2014 Apr; 13(4):278-89. PubMed ID: 24525781
[TBL] [Abstract][Full Text] [Related]
15. Update on the protective molecular pathways improving pancreatic beta-cell dysfunction.
Puddu A; Sanguineti R; Mach F; Dallegri F; Viviani GL; Montecucco F
Mediators Inflamm; 2013; 2013():750540. PubMed ID: 23737653
[TBL] [Abstract][Full Text] [Related]
16. Investigational agents that protect pancreatic islet beta-cells from failure.
Aston-Mourney K; Proietto J; Andrikopoulos S
Expert Opin Investig Drugs; 2005 Oct; 14(10):1241-50. PubMed ID: 16185166
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P
J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296
[TBL] [Abstract][Full Text] [Related]
18. Puerarin protects pancreatic β-cell survival via PI3K/Akt signaling pathway.
Li Z; Shangguan Z; Liu Y; Wang J; Li X; Yang S; Liu S
J Mol Endocrinol; 2014 Aug; 53(1):71-9. PubMed ID: 24827001
[TBL] [Abstract][Full Text] [Related]
19. Treat-to-target HbA
Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
[TBL] [Abstract][Full Text] [Related]
20. The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror.
Martínez MS; Manzano A; Olivar LC; Nava M; Salazar J; D'Marco L; Ortiz R; Chacín M; Guerrero-Wyss M; Cabrera de Bravo M; Cano C; Bermúdez V; Angarita L
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
